Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec:145:110335.
doi: 10.1016/j.mehy.2020.110335. Epub 2020 Oct 7.

Is a COVID-19 vaccine developed by nature already at work?

Affiliations

Is a COVID-19 vaccine developed by nature already at work?

Nilesh Kumar Sharma et al. Med Hypotheses. 2020 Dec.

Abstract

The COVID-19 positive cases are increasing at an alarming rate across the world. On the contrary, the morbidity and mortality are showing decreasing trend as time progresses. The most intriguing part is the rise in asymptomatic Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) positive cases in the population, which made us speculate some kind of gradual development of immunity in the population. To date, no attention has been given to the accumulation of killed/inactivated/degenerated SARS-CoV-2 associated molecular particle patterns (SAMPPs). In this paper, we introduced the concept of SAMMPs and its existence on inanimate objects is quite conceivable due to the size of SARS-CoV-2 and exuberant shedding of the virus in respiratory secretions. SAMPPs can come into the contact with mucosal surfaces and thereof associated antigen-presenting dendritic cells. Thus, we hypothesized the existence of SAMPPs mediated the development of immunity against SARS-CoV-2 infection, which has caused an increase in the incidence rate of asymptomatic cases and a decrease in mortality rate. To understand the existence of SAMPPs associated natural immunity against SARS-CoV-2, future population based serological testing are recommended to investigate serum antibody levels against various molecular particles associated with SAMPPs.

Keywords: COVID-19; Coronavirus; Immunity; SARS-CoV-2; Vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Flowchart depicting mechanism of SARS-CoV-2 associated molecular particles pattern as a nature made vaccine.

References

    1. Han Y.-J., Ren Z.-G., Li X.X. Advances and challenges in the prevention and treatment of COVID-19. Int J Med Sci. 2020;17(12):1803–1810. - PMC - PubMed
    1. Herrera-Lasso Regás V., Dordal Culla M.T., Lleonart Bellfill R. Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS-CoV-2. Medicina Clínica. 2020 doi: 10.1016/j.medcli.2020.06.019. - DOI - PMC - PubMed
    1. Jackson L.A., Anderson E.J., Rouphael N.G. An mRNA vaccine against SARS-CoV-2 – preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2022483. NEJMoa2022483 [published online ahead of print, 2020 Jul 14] - DOI - PMC - PubMed
    1. https://www.worldometers.info/coronavirus/.
    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. - PMC - PubMed